Astrana Health, Inc.

NASDAQ:ASTH

Medical - Care Facilities

Healthcare
$29.65 +2.70%

+$1.03 today

Market cap
$1.47B
Beta
0.94
P/E (TTM)
63.3
EPS (TTM)
$0.62
52W Low $18.08High $40.13

Volume 0.52M

Average 0.51M

ASTH Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Astrana Health, Inc.NASDAQ: ASTH

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit growth accelerates

Q1 FY2026 gross profit of $90.27M rose 26.5% year over year, ahead of the +19.9% change in trailing-twelve-month gross profit. Sequentially, it rose 14.8% from the prior quarter. Over 3 fiscal years it compounded at +14.0% a year.

Context

  • Gross profit amounted to 9.3% of revenue in FY2025, down 4.0 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +26.5% holds above the trailing-twelve-month pace of +19.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$90.27M+14.8% QoQ
Last fiscal yearDec 2025
$295.78M+9.0% YoY
LTMMar 2026
$328.47M+19.9% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+26.5%——
1 year+9.0%——
3-year CAGR+14.0%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
295.78M USD
Year-over-year change
+9.0%
4-year CAGR
+13.6%

Gross Profit vs competitors

How ASTH compares with its peers on the latest reported figures

  • ASTH's LTM Mar 2026 gross profit of $328.47M is the 2nd highest of the 4 companies compared; the peer median is $179.46M.
  • Its year-over-year change of +19.9% is the 2nd highest of 4, against a peer median of -3.9%.
  • Gross profit amounts to 9.3% of revenue for ASTH, versus a peer median of 7.6%.
ASTH Competitors Peer median
Gross Profit for ASTH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NUTXNutex Health, Inc.LTM Mar 2026$417.67M +37.2%+206.6%47.5%
ASTHAstrana Health, Inc.LTM Mar 2026$328.47M +19.9%+14.0%9.3%
PRVAPrivia Health Group, Inc.LTM Jun 2026$179.46M -3.9%+15.8%7.6%
AGLAgilon Health, Inc.LTM Mar 2026-$159.48M -716.8%—2.7%
Peer median (excluding ASTH) $179.46M-3.9%+111.2%7.6%

Competitors are the stored peer set for ASTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue773.92M1.14B1.39B2.03B3.18B
Cost of Revenue596.14M944.69M1.17B1.76B2.89B
Gross Profit177.77M199.48M214.96M271.39M295.78M
Gross Margin23.0%17.4%15.5%13.3%9.3%
Research & Development00000
Selling, General & Admin62.08M77.67M112.6M154.11M217.26M
Operating Expenses79.59M95.21M130.35M182.04M217.26M
Depreciation & Amortization17.52M17.54M17.75M27.93M45.75M
EBITDA100.66M112.08M123.69M141.84M135.28M
EBITDA Margin13.0%9.8%8.9%7.0%4.3%
Operating Income98.18M104.27M84.61M89.35M78.53M
Operating Margin12.7%9.1%6.1%4.4%2.5%
Interest Income1.57M1.98M14.21M14.51M12.16M
Interest Expense5.39M7.92M16.1M33.1M49.93M
Other Income / Expenses(20.43M)(17.65M)5.23M(8.53M)(38.92M)
Income Before Tax77.75M86.62M89.84M80.82M39.61M
Pre-Tax Margin10.0%7.6%6.5%4.0%1.2%
Income Tax Expense31.69M40.88M31.99M30.89M15.53M
Net Income68.92M45.17M60.72M43.15M22.49M
Net Margin8.9%3.9%4.4%2.1%0.7%
EPS (Basic)1.571.001.300.910.46
EPS (Diluted)1.520.991.290.900.46
Weighted Avg Shares43.83M44.97M46.71M47.69M49.08M
Weighted Avg Shares (Diluted)45.4M45.6M47.07M48.22M49.37M

Astrana Health, Inc.

NASDAQ:ASTH

Intrinsic Alpha fair value

Locked

Current Price

$29.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.